Medsafe has granted Comirnaty

Medical Information
New Zealand
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for New Zealand Healthcare Professionals. Would you like to proceed?

January 20, 2022
Medsafe has granted Comirnaty™ (BNT162b2 [mRNA]/tozinameran) COVID-19 Vaccine provisional consent for active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, in individuals 5 years of age and older. The use of this vaccine should be in accordance with official recommendations.